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BACKGROUND
Lipoid pneumonia (LP), also known as pulmonary ste-
atosis or pulmonary lipidosis, is an uncommon chronic 
inflammation of the lung parenchyma with interstitial in-
volvement caused by the accu mulation of oily material in 
the alveoli. Chronic constipation is a common symptom 
in pediatrics, and physicians often use mineral oil to treat 
intestinal constipation in children. The accidental aspira-
tion of lipid formulations is the most frequent cause of ex-
ogenous lipoid pneumonia in pediatrics1.
The radiological feature of the lipoid pneumonia can 
mimic many other lung diseases, including infections and 
carcinoma. Diagnosis of the lipoid pneumonia is often de-
layed or missed due to the nonspecific clinical manifesta-
tion and radiological appearances1. Given this scenario, a 
report on a patient with a history of chronic constipation 
and mineral oil ingestion is presented.
CASE REPORT
A four-month-old boy was admitted to the Hospital Uni-
versitário Materno-infantil (Universidade Federal do Ma-
ranhão) presenting diarrhea (frequency of 10 evacuations 
a day with mucus, without blood), increasing of abdominal 
volume, fever, and vomiting for 10 days. The patient had 
a history of meconium ileus, evacuating for the first time 
within ten days. After the initial 10 days, the patient had 
persistent difficulty in evacuation. Due to these circum-
stances, his mother had been administering mineral oil.
In addition, he was presenting cough without se-
cretion and tachypnea for two days. He was exclusively 
breastfed, and his scheduled vaccines were completed. 
At the physical exam he was slightly pale, with tachy-
pnea (requiring 5 L/min of mask oxygen 60%), dehydra-
tion, cyanosis, and jaundice; although feverless. Pulmo-
nary auscultation showed a rude vesicular breath sound 
with softer rhonchi. In the laboratory exams, leukocy-
tosis (66.8% neutrophils, 26.0% lymphocytes), positive 
C-reactive protein, 8.85 g/dL of hemoglobin, and serum 
protein of 4.1 g/dL (albumin: 2.9 g/dL and globulin: 
1.2 g/dL) were found. Chest radiography showed an infil-
trate in the apical regions in both lungs (Figure 1). The first 
diagnosis was community-acquired pneumonia. Thus, 
empiric antibiotic therapy was started with ampicillin 
gentamicin (5 mg/kg/day). Four days later, his intestinal 
presentation had improved, but he still presented crackles 
and rhonchi in the pulmonary auscultation. Thirteen days 
later, he started presenting febrile peaks and a new chest 
radiograph was requested, still showing opacities in the 
parenchymal of both lungs (Figure 1).
One week later, he was having daily febrile peaks de-
spite the antibiotics. Requests were made for a chest com-
puted tomography (CT); a gastric lavage for tuberculosis 
research (three samples), which came negative; and an-
other hemogram and CRP, that were normal. CT showed 
extensive consolidations and geographic ground glass 
opacities in both lungs, without any hilar lymphadenopa-
thy, volume loss, mass, or airway compression (Figure 2). 
Bronchoscopy with bronchoalve olar lavage (BAL) 
was performed and 10 mL of an opalescent fluid were 
divided in three samples. The samples were centrifuged 
and then analyzed using hematoxylin and eosin staining. 
Figure 1 – Chest radiograph showing parenchymal opacities 
in apical regions both lungs.
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The microscopic exam showed amorphous material, with 
inflammatory, red blood, cylindrical, and epithelial cells 
isolated and grouped. The exam also displayed frequent 
macrophages, some of then xanthomized and with lipid 
vacuoles (Figure 3). Thus, with the bronchoscopy, the diag-
nosis of LP was made. Our patient was in a stable condition 
and therefore discharged from hospital one month later, 
but with instructions to take prednisone 1 mg/kg/day for 
30 days. Follow-up was conducted at the hospital pulmon-
ology service. The follow-up chest radiographies showed a 
partial decrease of the parenchymal lesion, and the child 
was in good condition, without any clinical manifestations.
DISCUSSION
Lipoid pneumonia can be classified as endogenous, idio-
pathic or exogenous. Endogenous LP, also called choles-
terol pneumonitis, is less frequent and generally observed 
in patients with chronic bronchial obstruction of the air-
ways by tumors, bronchiolitis obliterans, and lipid storage 
diseases such as Gaucher’s disease and Niemann-Pick dis-
ease. Idiopathic LP is a rare disorder and has been associ-
ated with smoking in healthy individuals. Although exog-
enous LP is well documented in both pediatric and adult 
medical literature, it also occurs in the pediatric popula-
tion as a rare condition caused by aspiration of mineral, 
vegetable, or animal oils. The use of mineral oil in the 
treatment of constipation or as an adjuvant treatment 
for partial bowel obstruc tion by Ascaris lumbricoides has 
been well accepted because of its efficacy and infrequent 
side effects1-3.
In general, children present a widespread acute aspi-
ration condition which progresses to respiratory failure 
and, sometimes, death. The presence of increasing dys-
pnea, cough, chest pain, fever, and vomit, together with 
alveolar infiltrates in the chest X-rays and the previous ac-
cidental ingestion of an oily substance, should be cause for 
suspicion of exogenous lipoid pneumonia. Moreover, the 
presence of oil in the lungs predisposes to recurrent infec-
tions, and in rare cases can be complicated by atypical my-
cobacterial and cryptococcal infection. These infections 
result in a bronchoalveolar macrophage response, fol-
lowed by the release of inflammatory mediators, leading 
to fever, leukocytosis, neutrophilia, and elevated eryth-
rocyte sedimentation rate. Due to its nonspecific clinical 
presentation and radiographic signs, exogenous LP can 
mimic other pulmonary diseases, such as bacterial pneu-
monia, tuberculosis, cystic fibrosis, bronchiectasis, and 
tumors2,4,5.
Currently, analysis of the bronchoalve olar lavage 
(BAL) fluid is consid ered the diagnostic method of choice 
for suspected cases of LP, and only the cytochemical ex-
amination using staining can confirm the diagnosis6. Both 
Figure 2 – Computed tomography (CT) of the chest showing 
extensive consolidations and geographic ground glass opaci-
ties in both lungs.
Figure 3 – Inﬂammatory reaction with lymphocytic inﬁltration collection of lipid-laden alveolar macrophages and free oil mas-
ses from the lung (hematoxylin and eosin staining/magniﬁcation, x 400).
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high resolution computed tomography (HRCT) and mag-
netic resonance imaging have showed suggestive signs 
of lipid infiltration of pulmonary parenchyma. However, 
HRCT is the best imaging modality for the diagnosis of 
exogenous LP5,7,8.
In a recent review article, Marchiori et al.5 reported that 
there are still no studies in the literature that establish the 
best therapeutic option for LP. Nevertheless, the key pro-
cedure is interrupting the use of mineral oil, which leads 
to significant clinical improve ment. Due to the fact that 
the depuration of the inhaled oil is a slow process, the best 
therapeutic strategy would be to withdraw the oil as soon 
as possible through bronchoscopy with multiple BALs6.
Gondouin et al.9, in a retrospective multicenter study, 
found that corticosteroid therapy has not been very ef-
fective for all cases of lipoid pneumonia. The use of sys-
temic corticosteroids in patients without clinical symp-
toms remains controversial. However, whole lung lavage, 
thoracoscopy with surgical debridement, and systemic 
corticosteroids have been used in patients with diffuse 
pulmonary damage. Corticosteroid therapy has also been 
suggested in cases in which functional and radiologi-
cal alterations continue despite clinical improvement5,10. 
Even though some retrospective case series demonstrated 
no benefit in the use of corticosteroids, the patient had 
a good response after this therapy, and remained asymp-
tomatic at follow-up visits.
The present case emphasizes the need for increased 
awareness among caregivers and pediatricians about the 
potential hazards of mineral oil use for chronic constipa-
tion. Currently, despite no consensus on treatment, bron-
choalveolar lavage seems to be an efficient therapeutic 
measure for the clearance of mineral oil from the lung 
parenchyma. This procedure may contribute to preventing 
fibrosis and reducing the morbidity of lipoid pneumonia, 
which remains a rare diagnosis. 
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